BPTH
BPTH clinical trials: BIO-PATH HOLDINGS, INC.
Every trial on ClinicalTrials.gov where BIO-PATH HOLDINGS, INC. is the lead sponsor or a listed collaborator, the trials it leads first, each labelled Lead or Collaborator. Phase, status and dates as registered.
- 6
- Trials linked
- 6
- As lead sponsor
- 0
- As collaborator
- 0
- Primary completions as lead sponsor, next 90 days
BPTH on the catalyst calendar · BPTH registry changes
- Primary completion Mar 2027Sponsor estimatePhase 1NCT05190471A Clinical Trial of BP1002 in Patients With Refractory/Relapsed Acute Myeloid Leukemia (AML)Bio-Path Holdings, Inc. · Acute Myeloid Leukemia, in RelapseRecruitingBPTHLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jul 2027Sponsor estimatePhase 1NCT04196257BP1001-A in Patients With Advanced or Recurrent Solid TumorsBio-Path Holdings, Inc. · Solid Tumor, AdultRecruitingBPTHLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Dec 2027Sponsor estimatePhase 2NCT02781883Clinical Trial of BP1001 in Combination With With Venetoclax Plus Decitabine in AMLBio-Path Holdings, Inc. · Acute Myeloid Leukemia (AML)RecruitingBPTHLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Apr 2025Sponsor estimatePhase 1NCT04072458A Clinical Trial of BP1002 in Patients With Advanced Lymphoid MalignanciesBio-Path Holdings, Inc. · Mantle Cell LymphomaActive, not recruitingBPTHLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion May 27, 2020ActualPhase 1/Phase 2NCT02923986Clinical Trial of BP1001 (Liposomal Grb2 Antisense Oligonucleotide) in Combination With Dasatinib in Patients With Ph + CML Who Have...Bio-Path Holdings, Inc. · Chronic Myelogenous Leukemia, Ph1-PositiveWithdrawnBPTHLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Mar 30, 2017ActualPhase 1NCT01159028Clinical Trial of BP1001 (L-Grb-2 Antisense Oligonucleotide) in CML, AML, ALL & MDSBio-Path Holdings, Inc. · Recurrent Adult Acute Myeloid LeukemiaCompletedBPTHLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
Enrollment, interventions and the start and completion dates are locked on 6 rows here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.
Unlock with TrialScanner